Scribe Therapeutics, Inc. (SCTX)
20.67
-0.50
(-2.36%)
USD |
NASDAQ |
Oct 12, 16:00
20.10
-0.57
(-2.76%)
Pre-Market: 08:46
Scribe Therapeutics Total Liabilities (Quarterly) : 102.42M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 102.42M |
| Date | Value |
|---|---|
| March 31, 2026 | 103.59M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.555B |
| Twist Bioscience Corp. | 226.70M |
| Veracyte, Inc. | 97.96M |
| Cypherpunk Technologies, Inc. | 3.65M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 57.93M |
| Shareholders Equity (Quarterly) | -44.49M |
| Debt to Equity Ratio | -0.9726 |
| Current Ratio | 0.5731 |